Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

Koji Ishida, Kosuke Kaji, Shinya Sato, +8

The Journal of Nutritional Biochemistry

InflammationAcetaldehyde MetabolizationHepatologyBiochemistryMedicine +12

Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease

Kazuki Tahara, Takemi Akahane, Tadashi Namisaki, +21

JGH Open

Changes in voluntary and electrically induced contractions during strength training and detraining

Koji Ishida, Toshio Moritani, Kazuo Itoh

European Journal of Applied Physiology

Induced ContractionsMuscle FunctionKinesiologyPhysical FitnessPhysiology +9

Cardiorespiratory response at the onset of passive leg movements during sleep in humans

Koji Ishida, Yoshifumi Yasuda, Miharu Miyamura

European Journal of Applied Physiology

Upright PostureSleepCardiorespiratory ResponseKinesiologySleep-related Breathing Disorder +11

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

Hirotetsu Takagi, Kosuke Kaji, Norihisa Nishimura, +9

Cells

Chemoprevention StrategyImmunologyPharmacotherapyCancer BiologyMolecular Pharmacology +16

Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis.

Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, +17

Journal of Clinical Oncology

Surgical OncologyCancer ManagementPathologySurgeryTumor Biology +19

Post‐challenge hyperglycaemia is an independent risk factor for arterial stiffness in Japanese men

Kayo Ohshita, K. Yamane, Koji Ishida, +3

Diabetic Medicine

Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis.

Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, +17

Journal of Clinical Oncology

Surgical OncologyImmunodeficienciesImmunologyPathologySurgery +26

Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma

Hiroaki Takaya, Tadashi Namisaki, Kei Moriya, +14

World Journal of Gastroenterology

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

Hiroyuki Ogawa, Kosuke Kaji, Norihisa Nishimura, +8

Journal of Cellular and Molecular Medicine